Jean-Pierre Crinelli
Oprichter bij NOVACYT
Vermogen: 24 200 $ op 31-05-2024
Profiel
Jean-Pierre Crinelli is the founder of Novacyt SAS, where he holds the title of Independent Non-Executive Director starting in 2006.
He currently holds positions as a Non-Executive Director at Novacyt UK Holdings Ltd., Manager at SCI Padapi, and Member-Management Board at Alain Fresard Technologies-Micromecanique.
He formerly held the position of Chairman at CUP 92 SAS.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NOVACYT SAS
0.05% | 31-12-2022 | 33 981 ( 0.05% ) | 24 200 $ | 31-05-2024 |
Actieve functies van Jean-Pierre Crinelli
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVACYT | Oprichter | 03-07-2006 |
| SCI Padapi | Corporate Officer/Principal | - |
| Alain Fresard Technologies-Micromecanique | Corporate Officer/Principal | - |
Novacyt UK Holdings Ltd.
 Novacyt UK Holdings Ltd. BiotechnologyHealth Technology Part of Novacyt SAS, Novacyt UK Holdings Ltd. is a diagnostics company that develops tests that detect infections. The company is based in Eastleigh, UK. The British company was founded in 2019. The CEO is James Martin Mccarthy. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Jean-Pierre Crinelli
| Bedrijven | Functie | Einde |
|---|---|---|
CUP 92 SAS
 CUP 92 SAS Medical SpecialtiesHealth Technology CUP 92 SAS operates as a holding company with interest in the provision of solutions in cytology and molecular biology fields. The company was founded on March 11, 2010 and is headquartered in Compiegne, France. | Voorzitter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NOVACYT | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
CUP 92 SAS
CUP 92 SAS Medical SpecialtiesHealth Technology CUP 92 SAS operates as a holding company with interest in the provision of solutions in cytology and molecular biology fields. The company was founded on March 11, 2010 and is headquartered in Compiegne, France. | Health Technology |
| SCI Padapi | |
| Alain Fresard Technologies-Micromecanique | |
Novacyt UK Holdings Ltd.
Novacyt UK Holdings Ltd. BiotechnologyHealth Technology Part of Novacyt SAS, Novacyt UK Holdings Ltd. is a diagnostics company that develops tests that detect infections. The company is based in Eastleigh, UK. The British company was founded in 2019. The CEO is James Martin Mccarthy. | Health Technology |
